| Axon ID |
Name |
Description |
From price |
|
1128
|
Erlotinib hydrochloride
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1393
|
Gefitinib
|
EGFR tyrosine kinase inhibitor |
€70.00 |
|
1395
|
Lapatinib ditosylate
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1398
|
Sunitinib malate
|
Multi-targeted receptor tyrosine kinase inhibitor |
€80.00 |
|
1411
|
Vandetanib
|
VEGFR and EGFR tyrosine kinase inhibitor |
€50.00 |
|
1414
|
AG 013736
|
PDGFR,c-KIT and VEGFR tyrosine kinase inhibitor |
€50.00 |
|
1420
|
Pazopanib hydrochloride
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€60.00 |
|
1433
|
CI 1033
|
EGFR tyrosine kinase inhibitor |
€60.00 |
|
1461
|
Cediranib
|
VEGFR tyrosine kinase inhibitor |
€70.00 |
|
1506
|
WZ 4002
|
EGFR kinase inhibitor (T790M specific) |
€70.00 |
|
1526
|
Neratinib
|
EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€80.00 |
|
1537
|
CP 724714
|
ErbB-2/HER2 kinase inhibitor |
€80.00 |
|
1547
|
OSI 930
|
c-Kit and VEGFR2 tyrosine kinase inhibitor |
€90.00 |
|
1632
|
OSI 420
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1637
|
Vatalanib
|
VEGFR tyrosine kinase inhibitor |
€75.00 |
|
1638
|
ABT 869
|
PDGFR, c-KIT and VEGFR tyrosine kinase inhibitor |
€85.00 |
|
1653
|
AEE 788
|
EGFR, ErbB2 and VEGFR tyrosine kinase inhibitor |
€80.00 |
|
1662
|
CP 547632
|
VEGFR2 tyrosine kinase inhibitor |
€70.00 |
|
1665
|
Pelitinib
|
EGFR tyrosine kinase inhibitor |
€90.00 |
|
1678
|
Regorafenib
|
Multi-kinase RTK inhibitor |
€70.00 |
|
1717
|
Tivozanib
|
VEGFR1, 2, and 3 tyrosine kinase inhibitor |
€80.00 |
|
1760
|
EGFR Inhibitor [879127-07-8]
|
Highly selective EGFR tyrosine kinase inhibitor |
€120.00 |
|
1768
|
AMG 706
|
Multiple receptor tyrosine kinase inhibitor |
€105.00 |
|
1819
|
Cabozantinib S-malate
|
Inhibitor of multiple receptor tyrosine kinases, specifically MET and VEGFR2 |
€60.00 |
|
1850
|
BMS 540215
|
Inhibitor of VEGFR (subtype 2 and 3 selective) |
€110.00 |
|
1864
|
Brivanib alaninate
|
Prodrug of BMS 540215; Inhibitor of VEGF |
€90.00 |
|
1891
|
SU 6668
|
Inhibitor of RTK targeting PDGFR, VEGF and FGFR |
€100.00 |
|
1942
|
E 3810 dihydrochloride
|
Dual VEGFR/FGFR tyrosine kinase inhibitor |
€90.00 |
|
1959
|
Golvatinib
|
Potent and orally available inhibitor of c-MET (HGFR) and VEGFR2 |
€90.00 |
|
1963
|
LY 573636
|
Anti-tumor agent; causes growth arrest and apoptosis |
€80.00 |
|
1978
|
ZM 323881 hydrochloride
|
Inhibitor of VEGFR2 |
€105.00 |
|
1986
|
AST 1306 tosylate
|
ErbB2 and EGFR inhibitor |
€90.00 |
|
2053
|
TAK 165
|
ErbB2/HER2 kinase inhibitor |
€60.00 |
|
1667
|
SU 5402
|
Fibroblast growth factor receptor (FGFR) inhibitor |
€60.00 |
|
2342
|
AZD9291
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
2563
|
AZD3759
|
Potent, orally active, brain-penetrant, EGFR tyrosine kinase inhibitor |
€85.00 |
|
2560
|
Tilfrinib
|
Brk inhibitor with antiproliferative activity in breast tumor cells |
€95.00 |
|
2680
|
EAI045
|
Allosteric EGFR inhibitor (L858R/T790M-specific) |
€105.00 |
|
2767
|
SU11652
|
Multi-targeted receptor tyrosine kinase inhibitor |
€140.00 |
|
2920
|
Poziotinib
|
Irreversible pan-HER inhibitor |
€95.00 |
|
2955
|
NSC 228155
|
EGFR tyrosine kinase activator; Inhibitor of KIX-KID interaction |
€75.00 |
|
3040
|
Abivertinib
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
|
3192
|
EMI48
|
Inhibitor of EGFR triple mutants |
€120.00 |
|
3232
|
TAK-788
|
Potent and selective EGFR and ErbB-2/HER2 tyrosine kinase inhibitor |
€70.00 |
|
3235
|
Dacomitinib
|
Potent irreversible pan-HER inhibitor |
€60.00 |
|
3802
|
TAS6417
|
EGFR inhibitor |
Inquire |
|
3853
|
BMS-599626
|
Potent and selective EGFR and ErbB2 inhibitor |
Inquire |
|
3862
|
BGB-283
|
Orally available dual RAF kinase/EGFR inhibitor |
Inquire |
|
4074
|
AZ5104
|
EGFR inhibitor |
Inquire |
|
4138
|
CUDC-101
|
Potent HDAC, EGFR, and HER2 inhibitor |
Inquire |
|
4130
|
PELI1/EGFR disruptor S62
|
Potent PELI1/EGFR disruptor |
€130.00 |